A detailed history of New York State Common Retirement Fund transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 600 shares of PYXS stock, worth $2,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 31,200 98.08%
Holding current value
$2,490
Previous $103,000 98.06%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$2.83 - $3.94 $86,598 - $120,564
-30,600 Reduced 98.08%
600 $2,000
Q2 2024

Jul 31, 2024

BUY
$3.06 - $5.58 $95,472 - $174,096
31,200 New
31,200 $103,000
Q2 2022

Aug 04, 2022

SELL
$2.02 - $4.53 $12,679 - $28,434
-6,277 Reduced 98.31%
108 $0
Q1 2022

May 05, 2022

BUY
$4.04 - $11.43 $436 - $1,234
108 Added 1.72%
6,385 $26,000
Q4 2021

Feb 02, 2022

BUY
$8.39 - $13.64 $52,664 - $85,618
6,277 New
6,277 $69,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $146M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.